Literature DB >> 26671981

Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Francesca Gasparrini1, Christoph Feest1, Andreas Bruckbauer1, Pieta K Mattila1, Jennifer Müller2, Lars Nitschke2, Dennis Bray3, Facundo D Batista4.   

Abstract

Receptor organization and dynamics at the cell membrane are important factors of signal transduction regulation. Using super-resolution microscopy and single-particle tracking, we show how the negative coreceptor CD22 works with the cortical cytoskeleton in restraining BCR signalling. In naïve B cells, we found endogenous CD22 to be highly mobile and organized into nanodomains. The landscape of CD22 and its lateral diffusion were perturbed either in the absence of CD45 or when the CD22 lectin domain was mutated. To understand how a relatively low number of CD22 molecules can keep BCR signalling in check, we generated Brownian dynamic simulations and supported them with ex vivo experiments. This combined approach suggests that the inhibitory function of CD22 is influenced by its nanoscale organization and is ensured by its fast diffusion enabling a "global BCR surveillance" at the plasma membrane.
© 2015 The Authors.

Entities:  

Keywords:  B‐cell receptor signalling; glycoprotein CD45; membrane dynamics; siglec CD22; super‐resolution microscopy

Mesh:

Substances:

Year:  2015        PMID: 26671981      PMCID: PMC4741297          DOI: 10.15252/embj.201593027

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  82 in total

1.  Plasma membrane-associated proteins are clustered into islands attached to the cytoskeleton.

Authors:  Björn F Lillemeier; Janet R Pfeiffer; Zurab Surviladze; Bridget S Wilson; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

2.  CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand.

Authors:  David Depoil; Sebastian Fleire; Bebhinn L Treanor; Michele Weber; Naomi E Harwood; Kevin L Marchbank; Victor L J Tybulewicz; Facundo D Batista
Journal:  Nat Immunol       Date:  2007-12-02       Impact factor: 25.606

3.  CD22 is a negative regulator of B-cell receptor signalling.

Authors:  L Nitschke; R Carsetti; B Ocker; G Köhler; M C Lamers
Journal:  Curr Biol       Date:  1997-02-01       Impact factor: 10.834

4.  The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling.

Authors:  Pieta K Mattila; Christoph Feest; David Depoil; Bebhinn Treanor; Beatriz Montaner; Kevin L Otipoby; Robert Carter; Louis B Justement; Andreas Bruckbauer; Facundo D Batista
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

5.  High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.

Authors:  Brian E Collins; Ola Blixt; Shoufa Han; Bao Duong; Hongyi Li; Jay K Nathan; Nicolai Bovin; James C Paulson
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Confined lateral diffusion of membrane receptors as studied by single particle tracking (nanovid microscopy). Effects of calcium-induced differentiation in cultured epithelial cells.

Authors:  A Kusumi; Y Sako; M Yamamoto
Journal:  Biophys J       Date:  1993-11       Impact factor: 4.033

7.  Tyrosine phosphorylation of CD22 during B cell activation.

Authors:  R J Schulte; M A Campbell; W H Fischer; B M Sefton
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

8.  Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization.

Authors:  Nicholas L Andrews; Keith A Lidke; Janet R Pfeiffer; Alan R Burns; Bridget S Wilson; Janet M Oliver; Diane S Lidke
Journal:  Nat Cell Biol       Date:  2008-07-20       Impact factor: 28.824

9.  Translational diffusion of class II major histocompatibility complex molecules is constrained by their cytoplasmic domains.

Authors:  W F Wade; J H Freed; M Edidin
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

10.  Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.

Authors:  Lei Jin; Paul A McLean; Benjamin G Neel; Henry H Wortis
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  36 in total

1.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

Review 2.  Cytoskeletal control of B cell responses to antigens.

Authors:  Pavel Tolar
Journal:  Nat Rev Immunol       Date:  2017-07-10       Impact factor: 53.106

3.  B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.

Authors:  Xiao-Na Wang; Xin Ge; Jing Li; Xiao Liu; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

4.  Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation.

Authors:  Madison Bolger-Munro; Kate Choi; Joshua M Scurll; Libin Abraham; Rhys S Chappell; Duke Sheen; May Dang-Lawson; Xufeng Wu; John J Priatel; Daniel Coombs; John A Hammer; Michael R Gold
Journal:  Elife       Date:  2019-06-03       Impact factor: 8.140

5.  IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate.

Authors:  Mark Noviski; James L Mueller; Anne Satterthwaite; Lee Ann Garrett-Sinha; Frank Brombacher; Julie Zikherman
Journal:  Elife       Date:  2018-03-09       Impact factor: 8.140

Review 6.  Self-reactivity on a spectrum: A sliding scale of peripheral B cell tolerance.

Authors:  Corey Tan; Mark Noviski; John Huizar; Julie Zikherman
Journal:  Immunol Rev       Date:  2019-10-20       Impact factor: 12.988

Review 7.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

8.  Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.

Authors:  Kyle J Bednar; Elena Shanina; Romain Ballet; Edward P Connors; Shiteng Duan; Joana Juan; Britni M Arlian; Michael D Kulis; Eugene C Butcher; Wai-Ping Fung-Leung; Tadimeti S Rao; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-09-29       Impact factor: 5.422

Review 9.  Control of autoreactive B cells by IgM and IgD B cell receptors: maintaining a fine balance.

Authors:  Mark Noviski; Julie Zikherman
Journal:  Curr Opin Immunol       Date:  2018-10-05       Impact factor: 7.486

Review 10.  Siglec Ligands.

Authors:  Anabel Gonzalez-Gil; Ronald L Schnaar
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.